{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:21Z","timestamp":1793390841835,"version":"4.5.0"},"reference-count":347,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008802","name":"Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030887","name":"Central Council for Research in Unani Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020374","name":"Government of India Ministry of Ayush","doi-asserted-by":"publisher","award":["TECH-21013\/8\/2024-CCRUM-HQ"],"award-info":[{"award-number":["TECH-21013\/8\/2024-CCRUM-HQ"]}],"id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.prp.2025.156245","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:24:02Z","timestamp":1758698642000},"page":"156245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets"],"prefix":"10.1016","volume":"275","author":[{"given":"Kamini R.","family":"Shirasath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Zaheer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Karwasra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-5607","authenticated-orcid":false,"given":"Yogeeta O.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156245_bib1","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2025.156245_bib2","series-title":"Polycystic ovarian disease","author":"Rasquin","year":"2024"},{"key":"10.1016\/j.prp.2025.156245_bib3","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"10.1016\/j.prp.2025.156245_bib4","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0342","article-title":"Hormonal changes in PCOS","volume":"261","author":"Yang","year":"2024","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/cen.14704","article-title":"Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS)","volume":"97","author":"Garg","year":"2022","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2025.156245_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9240569","article-title":"Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Health Eng."},{"key":"10.1016\/j.prp.2025.156245_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su","year":"2025","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2025.156245_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66633-2","article-title":"Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes","volume":"10","author":"Hong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib9","article-title":"Genetic and epigenetic landscape for drug development in polycystic ovary syndrome","volume":"45","author":"C","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12902-020-0497-6","article-title":"Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.prp.2025.156245_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156245_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","article-title":"Gut microbiome May contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis","volume":"50","author":"Jiao","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.prp.2025.156245_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12916-023-02975-8","article-title":"Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"21","author":"Li","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.prp.2025.156245_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/0115701611269146230920073301","article-title":"Cardiometabolic risk, peripheral arterial disease and cardiovascular events in polycystic ovary syndrome: time to implement systematic screening and update the management","volume":"21","author":"Janez","year":"2023","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib15","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib16","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.3390\/ijms25169037","article-title":"The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature","volume":"25","author":"Chang","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.24976\/Discov.Med.202436184.88","article-title":"Ghrelin alleviates inflammation, insulin resistance, and reproductive abnormalities in mice with polycystic ovary syndrome via the TLR4-NF-\u03baB signaling pathway","volume":"36","author":"Liu","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.prp.2025.156245_bib18","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/jc.2014-4290","article-title":"Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood","volume":"100","author":"Rosenfield","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.prp.2025.156245_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1113840","article-title":"Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome","volume":"10","author":"Fu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.prp.2025.156245_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00656","article-title":"Anti-M\u00fcllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome","volume":"10","author":"Abbara","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-M\u00fcllerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of Anti-M\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome","volume":"11","author":"Dewailly","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib24","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/ijerph19053089","article-title":"Neuroendocrine determinants of polycystic ovary syndrome","volume":"19","author":"Szeliga","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.prp.2025.156245_bib25","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1210\/en.2019-00428","article-title":"Neuroendocrine impairments of polycystic ovary syndrome","volume":"160","author":"Ruddenklau","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2025.156245_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","article-title":"Abnormal GnRH pulsatility in polycystic ovary syndrome: recent insights","volume":"12","author":"McCartney","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.prp.2025.156245_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.14711","article-title":"Impaired steroid hormone feedback in polycystic ovary syndrome: evidence from preclinical models for abnormalities within central circuits controlling fertility","volume":"97","author":"Moore","year":"2022","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2025.156245_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2009156118","article-title":"Direct evidence that KNDy neurons maintain gonadotropin pulses and folliculogenesis as the GnRH pulse generator","volume":"118","author":"Nagae","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155556","article-title":"Dissecting the KNDy hypothesis: KNDy neuron-derived kisspeptins are dispensable for puberty but essential for preserved female fertility and gonadotropin pulsatility","volume":"144","author":"Velasco","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.prp.2025.156245_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6237141","article-title":"The correlation between hormonal disturbance in PCOS women and serum level of kisspeptin","volume":"2020","author":"Ibrahim","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab120","article-title":"Physiological characterization and transcriptomic properties of GnRH neurons derived from human stem cells","volume":"162","author":"Keen","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2025.156245_bib32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/humrep\/dex086","article-title":"Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome","volume":"32","author":"Kawwass","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ebiom.2019.05.065","article-title":"Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: implications for polycystic ovary syndrome","volume":"44","author":"Silva","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prp.2025.156245_bib34","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","article-title":"Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis","volume":"14","author":"Pratama","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47198","article-title":"Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism","volume":"8","author":"Malone","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.prp.2025.156245_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156245_bib37","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-Mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jsbmb.2012.02.003","article-title":"The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients","volume":"132","author":"Wang","year":"2012","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.prp.2025.156245_bib39","doi-asserted-by":"crossref","unstructured":"A. Purwar, S. Nagpure, Insulin Resistance in Polycystic Ovarian Syndrome, Cureus 14 (n.d.) e30351. https:\/\/doi.org\/10.7759\/cureus.30351.","DOI":"10.7759\/cureus.30351"},{"key":"10.1016\/j.prp.2025.156245_bib40","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/humrep\/dex308","article-title":"Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes","volume":"32","author":"Tosi","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib41","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic\u2013hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib42","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","article-title":"Effect of diet on insulin resistance in polycystic ovary syndrome","volume":"105","author":"Shang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.prp.2025.156245_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000529354","article-title":"Elevated Insulin-Like growth Factor-1-Induced female rats perpetuate the polycystic ovary syndrome phenotype: pathological mechanism of Insulin-Like growth Factor-1 in polycystic ovary syndrome","volume":"88","author":"Fu","year":"2023","journal-title":"Gynecol. Obstet. Invest"},{"key":"10.1016\/j.prp.2025.156245_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm. Res Paediatr."},{"key":"10.1016\/j.prp.2025.156245_bib47","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad033","article-title":"Insulin-Induced AKR1C3 induces fatty acid synthase in a model of human PCOS adipocytes","volume":"164","author":"Paulukinas","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2025.156245_bib48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib49","article-title":"Polycystic ovary syndrome as a metabolic disease","author":"Helvaci","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13679-023-00531-2","article-title":"Hypothalamic-Ovarian axis and adiposity relationship in polycystic ovary syndrome: physiopathology and therapeutic options for the management of metabolic and inflammatory aspects","volume":"13","author":"Lonardo","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000548","article-title":"Polycystic ovary syndrome: pathophysiology and therapeutic opportunities","volume":"2","author":"Dong","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.prp.2025.156245_bib52","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased Intra-Abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2023.102255","article-title":"Relationship between metabolic syndrome and polycystic ovary syndrome with special reference to C-Reactive protein","volume":"46","author":"Alissa","year":"2024","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.prp.2025.156245_bib54","first-page":"535","article-title":"Quantitative changes in White blood cells: correlation with the hallmarks of polycystic ovary syndrome","volume":"58","author":"Almaeen","year":"2022","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.prp.2025.156245_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/01443615.2011.553693","article-title":"Polycystic ovary syndrome and the peripheral blood White cell count","volume":"31","author":"Herlihy","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.prp.2025.156245_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/09513590.2016.1155208","article-title":"Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome","volume":"32","author":"Nehir Aytan","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4092470","article-title":"Inflammatory markers in women with polycystic ovary syndrome","volume":"2020","author":"Rudnicka","year":"2020","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.prp.2025.156245_bib58","doi-asserted-by":"crossref","DOI":"10.1515\/bmc-2022-0038","article-title":"Polycystic ovary syndrome and its management: in view of oxidative stress","volume":"15","author":"Bhattacharya","year":"2024","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.prp.2025.156245_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome","volume":"151","author":"Zhai","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.prp.2025.156245_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12958-021-00878-y","article-title":"Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation","volume":"20","author":"Dumesic","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib61","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1210\/jc.2012-2697","article-title":"PCOS is associated with increased CD11c expression and Crown-Like structures in adipose tissue and increased central abdominal fat depots independent of obesity","volume":"98","author":"Huang","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib62","article-title":"The role of macrophages in polycystic ovarian syndrome and its typical pathological features: a narrative review","volume":"167","author":"F. Y","year":"2023","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"10.1016\/j.prp.2025.156245_bib63","article-title":"Effect of TNF-alpha on endometrial glucose transporter-4 expression in patients with polycystic ovary syndrome through nuclear factor-kappa b signaling pathway activation","volume":"72","author":"Ha","year":"2021","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib64","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/1933719117732157","article-title":"Effect of TNF-\u03b1 on molecules related to the insulin action in endometrial cells exposed to hyperandrogenic and hyperinsulinic conditions characteristics of polycystic ovary syndrome","volume":"25","author":"Or\u00f3stica","year":"2018","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.141049","article-title":"Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice","volume":"745","author":"Wang","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.prp.2025.156245_bib66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.5468\/ogs.24031","article-title":"Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome","volume":"67","author":"Sen","year":"2024","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib67","doi-asserted-by":"crossref","DOI":"10.62110\/sciencein.jist.2024.v12.752","article-title":"Polycystic ovary syndrome (PCOS) and oxidative stress","volume":"12","author":"Sengupta","year":"2024","journal-title":"J. Integr. Sci. Technol."},{"key":"10.1016\/j.prp.2025.156245_bib68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0412.2011.01337.x","article-title":"Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome","volume":"91","author":"Baskol","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2025.156245_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12958-016-0205-6","article-title":"Relationship between advanced glycation end products and steroidogenesis in PCOS","volume":"14","author":"Garg","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.prp.2025.156245_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","article-title":"Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies","volume":"22","author":"Yan","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108717","article-title":"Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells","volume":"107","author":"Huang","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib73","article-title":"Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and mendelian randomization study","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib74","article-title":"Irisin alleviated the reproductive endocrinal disorders of PCOS mice accompanied by changes in gut microbiota and metabolomic characteristics","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.prp.2025.156245_bib75","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.prp.2025.156245_bib76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-025-01648-9","article-title":"A primary insight into gut microbiome, MicroRNA and stemness, in a PCOS rat model","volume":"18","author":"Esfandiarinezhad","year":"2025","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2025.156245_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frau"},{"key":"10.1016\/j.prp.2025.156245_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/JOE-19-0589","article-title":"The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome","volume":"245","author":"Qi","year":"2020","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib79","doi-asserted-by":"crossref","DOI":"10.1080\/07315724.2019.1657515","article-title":"A new approach to polycystic ovary syndrome: the gut microbiota","author":"Yurtda\u015f","year":"2020","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.prp.2025.156245_bib80","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/ijerph19031336","article-title":"Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment","volume":"19","author":"Parker","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.prp.2025.156245_bib81","doi-asserted-by":"crossref","first-page":"54801","DOI":"10.5539\/gjhs.v8n9p302","article-title":"Comparison of dietary intake between polycystic ovary syndrome women and controls","volume":"8","author":"Shishehgar","year":"2016","journal-title":"Glob. J. Health Sci."},{"key":"10.1016\/j.prp.2025.156245_bib82","article-title":"Exercise in the management of polycystic ovary syndrome: a position statement from exercise and sport science Australia","volume":"0","author":"Sabag","year":"2024","journal-title":"J. Sci. Med. Sport"},{"key":"10.1016\/j.prp.2025.156245_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247486","article-title":"Impact of polycystic ovary syndrome on quality of life of women in correlation to age, basal metabolic index, education and marriage","volume":"16","author":"Tabassum","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.prp.2025.156245_bib84","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"International PCOS network, recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prp.2025.156245_bib85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cca.2020.05.009","article-title":"Can environmental pollutant bisphenol a increase metabolic risk in polycystic ovary syndrome?","volume":"507","author":"Milanovi\u0107","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2025.156245_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/humrep\/dep381","article-title":"Occupational exposure to bisphenol-A (BPA) and the risk of self-reported Male sexual dysfunction","volume":"25","author":"Li","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib87","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.33549\/physiolres.933090","article-title":"Differences in bisphenol a and estrogen levels in the plasma and seminal plasma of men with different degrees of infertility","volume":"64","author":"Vitku","year":"2015","journal-title":"Physiol. Res"},{"key":"10.1016\/j.prp.2025.156245_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1324993","article-title":"The adverse role of endocrine disrupting chemicals in the reproductive system","volume":"14","author":"Pan","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib89","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/biomedicines10030540","article-title":"Polycystic ovarian syndrome: a complex disease with a genetics approach","volume":"10","author":"Nautiyal","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156245_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75719-0","article-title":"Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment","volume":"14","author":"Dhar","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib91","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib92","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/biomedicines13081912","article-title":"PCOS and the genome: is the genetic puzzle still worth solving?","volume":"13","author":"Palumbo","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156245_bib93","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2018-02496","article-title":"Family-Based quantitative trait Meta-Analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome","volume":"104","author":"Dapas","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib94","doi-asserted-by":"crossref","first-page":"E1519","DOI":"10.1073\/pnas.1400574111","article-title":"Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype","volume":"111","author":"McAllister","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156245_bib95","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib96","doi-asserted-by":"crossref","first-page":"352","DOI":"10.20945\/2359-3997000000049","article-title":"An update of genetic basis of PCOS pathogenesis","volume":"62","author":"Crespo","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib97","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib98","doi-asserted-by":"crossref","first-page":"D1032","DOI":"10.1093\/nar\/gkv1146","article-title":"PCOSKB: a KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic ovary syndrome","volume":"44","author":"Joseph","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2025.156245_bib99","doi-asserted-by":"crossref","unstructured":"L.M.E. Moolhuijsen, J. Zhu, B.H. Mullin, N. Pujol-Gualdo, K.V. Actkins, J.A. Mack, H. Rao, B. Trivedi, K.A. Kentistou, Y. Zhao, D. Westergard, J.S. Tyrmi, G. Thorleifsson, Y. Zhang, L. Wittemans, A. DeVries, K. Brewer, R. Sisk, R. Danning, M.H. Preuss, M.R. Jones, K.S. Ruth, M. Andersen, R. Azziz, K. Banasik, M. Boehnke, L. Broer, S. Brunak, Y.-M. Chan, D.I. Chasman, M. Daly, D.A. Ehrmann, B.C. Fauser, L.G. Fritsche, M.G. Hayes, C. He, H. Huang, I. Kowalska, P. Kraft, R.S. Legro, N. Lin, R.J. Loos, Y.V. Louwers, R. Magi, M.I. McCarthy, L. Morin-Papunen, J.V. Morrison, C. Morton, G.N. Nadkarni, B.M. Neale, H.S. Nielsen, M. Nyegaard, S.R. Ostrowski, O.B.V. Pedersen, E. S\u00f8rensen, C. Mikkelsen, C. Erikstrup, K.A. Kaspersen, M.T. Bruun, B. Aagaard, H. Ullum, B. Obermayer-Pietsch, A. Palotie, M.P. Reeve, A. Salumets, R. Saxena, T.D. Spector, B.G.A. Stuckey, U. Thorsteinsdottir, A.G. Uitterlinden, M. Urbanek, S. Zollner, G. and H.R. Team, D.G. Consortium, 23andMe Research Team, D.A.V. Heel, J.N. Hirschhorn, K. Stefansson, J.R.B. Perry, U. Styrkarsdottir, S.G. Wilson, T. Piltonen, T. Laisk, M.-R. Jarvelin, K. Burns, A.E. Justice, H. Laivuori, K.K. Ong, M.O. Goodarzi, L.K. Davis, A. Dunaif, C.M. Lindgren, J.S.E. Laven, S. Franks, J.A. Visser, C.K. Welt, T. Karaderi, F.R. Day, Genomic and proteomic evidence for hormonal and metabolic foundations of polycystic ovary syndrome, (2024) 2024.04.18.24306020. https:\/\/doi.org\/10.1101\/2024.04.18.24306020.","DOI":"10.1101\/2024.04.18.24306020"},{"key":"10.1016\/j.prp.2025.156245_bib100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","article-title":"Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target","volume":"10","author":"Chen","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2025.156245_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.prp.2025.156245_bib102","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: investigations and management","volume":"37","author":"Lizneva","year":"2016","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.prp.2025.156245_bib103","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2174\/1381612829666230331093912","article-title":"Do pleiotropic effects of spironolactone in women with PCOS make it more than an Anti-androgen? evidence from a systematic review and Meta-analysis","volume":"29","author":"Bashir","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2025.156245_bib104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","article-title":"Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis","volume":"18","author":"Zhao","year":"2021","journal-title":"Reprod. Health"},{"key":"10.1016\/j.prp.2025.156245_bib105","first-page":"1","article-title":"Metformin: update on mechanisms of action and repurposing potential","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cen.14983","article-title":"Effects of different insulin sensitisers in the management of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"100","author":"Melin","year":"2024","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib107","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/dom.14304","article-title":"Pioglitazone and bariatric surgery are the most effective treatments for non-alcoholic steatohepatitis: a hierarchical network meta-analysis","volume":"23","author":"Panunzi","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12325-012-0044-6","article-title":"Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials","volume":"29","author":"Du","year":"2012","journal-title":"Adv. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13048-024-01367-7","article-title":"Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial","volume":"17","author":"Zhao","year":"2024","journal-title":"J. Ovarian Res"},{"key":"10.1016\/j.prp.2025.156245_bib110","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1007\/s12325-024-02848-3","article-title":"The effect of thiazolidinediones in polycystic ovary syndrome: a systematic review and Meta-Analysis of randomised controlled trials","volume":"41","author":"Abdalla","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib111","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/cells13141171","article-title":"Inositol restores appropriate steroidogenesis in PCOS ovaries both in vitro and in vivo experimental mouse models","volume":"13","author":"Fedeli","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156245_bib112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","article-title":"Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Greff","year":"2023","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib113","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/nu13103665","article-title":"Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a One-Group Pretest-Post-Test explanatory study","volume":"13","author":"Rondanelli","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2025.156245_bib114","doi-asserted-by":"crossref","first-page":"760","DOI":"10.14336\/AD.2016.0620","article-title":"Rhizoma coptidis and berberine as a natural drug to combat aging and Aging-Related diseases via Anti-Oxidation and AMPK activation","volume":"8","author":"Xu","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.prp.2025.156245_bib115","article-title":"Effects of berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2025.156245_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155456","article-title":"Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression","volume":"128","author":"He","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prp.2025.156245_bib117","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cen.14013","article-title":"Effect of the combined oral contraceptive pill and\/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses","volume":"91","author":"Teede","year":"2019","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2025.156245_bib118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.14913","article-title":"Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review","volume":"99","author":"Forslund","year":"2023","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2025.156245_bib119","article-title":"Incidence rate of venous thrombosis in women switching combined oral contraceptives: a cohort study","volume":"8","author":"Khialani","year":"2024","journal-title":"Res Pr. Thromb. Haemost."},{"key":"10.1016\/j.prp.2025.156245_bib120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex Hormone-Binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","volume":"14","author":"Xing","year":"2022","journal-title":"Int J. Women\u2019s. Health"},{"key":"10.1016\/j.prp.2025.156245_bib121","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2025.156245_bib122","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/1471-0528.17268","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data","volume":"129","author":"Schink","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.prp.2025.156245_bib123","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpobgyn.2020.05.003","article-title":"Progesterone and endometrial cancer","volume":"69","author":"Gompel","year":"2020","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.prp.2025.156245_bib124","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","article-title":"Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"Forslund","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib125","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","article-title":"Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and Meta-analysis","volume":"109","author":"Melin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib126","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1016\/j.bmc.2010.05.061","article-title":"2-Acylamino-4,6-diphenylpyridine derivatives as novel GPR54 antagonists with good brain exposure and in vivo efficacy for plasma LH level in Male rats","volume":"18","author":"Kobayashi","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.prp.2025.156245_bib127","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2016-2132","article-title":"Interactions between neurokinin b and kisspeptin in mediating estrogen feedback in healthy women","volume":"101","author":"Skorupskaite","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib128","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/humrep\/dex357","article-title":"The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function","volume":"33","author":"Owens","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib129","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/dez205","article-title":"Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome","volume":"34","author":"Romero-Ruiz","year":"2019","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib130","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1021\/acs.jmedchem.6b00379","article-title":"Design and synthesis of an investigational nonapeptide KISS1 receptor (KISS1R) agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2 (TAK-448), with highly potent Testosterone-Suppressive activity and excellent water solubility","volume":"59","author":"Nishizawa","year":"2016","journal-title":"J. Med Chem."},{"key":"10.1016\/j.prp.2025.156245_bib131","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1523\/JNEUROSCI.5740-08.2009","article-title":"Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation","volume":"29","author":"Roseweir","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156245_bib132","first-page":"99","article-title":"Prenatal kisspeptin antagonist exposure prevents polycystic ovary syndrome development in prenatally-androgenized rats in adulthood: an experimental study","volume":"21","author":"Bakhi","year":"2023","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.prp.2025.156245_bib133","doi-asserted-by":"crossref","first-page":"e3519","DOI":"10.1210\/clinem\/dgab320","article-title":"Randomized controlled trial of neurokinin 3 receptor antagonist fezolinetant for treatment of polycystic ovary syndrome","volume":"106","author":"Fraser","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib134","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13543784.2024.2305122","article-title":"Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms","volume":"33","author":"Sassarini","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.prp.2025.156245_bib135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/GME.0000000000002138","article-title":"Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)","volume":"30","author":"Simon","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.prp.2025.156245_bib136","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.14618","article-title":"Elinzanetant for the treatment of vasomotor symptoms associated with menopause: OASIS 1 and 2 randomized clinical trials","author":"Pinkerton","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2025.156245_bib137","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/humrep\/den273","article-title":"Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome","volume":"23","author":"Ahmed","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/endrev\/bnad023","article-title":"The emerging therapeutic potential of kisspeptin and neurokinin B","volume":"45","author":"Patel","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib139","article-title":"Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study","volume":"24","author":"Am","year":"2001","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.prp.2025.156245_bib140","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","article-title":"Difelikefalin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.prp.2025.156245_bib141","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000534227","article-title":"Difelikefalin in Black\/African American hemodialysis patients with Moderate-to-Severe pruritus: post hoc analysis of KALM-1 and KALM-2","volume":"55","author":"Fishbane","year":"2024","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.prp.2025.156245_bib142","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"KALM-1 trial investigators, a phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.prp.2025.156245_bib143","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-024-01339-y","article-title":"Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review","volume":"23","author":"Duah","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib144","unstructured":"Naltrexone: Uses, Dosage, Side Effects, Warnings, Drugs.Com (n.d.). https:\/\/www.drugs.com\/naltrexone.html (accessed February 5, 2025)."},{"key":"10.1016\/j.prp.2025.156245_bib145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.prp.2025.156245_bib146","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1210\/clinem\/dgab602","article-title":"Inhibiting Kiss1 neurons with kappa opioid receptor agonists to trea polycystic ovary syndrome and vasomotor symptoms","volume":"107","author":"McCarthy","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib147","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12958-024-01269-9","article-title":"Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion","volume":"22","author":"Zhao","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib148","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1097\/CM9.0000000000001712","article-title":"Short-term combined treatment with exenatide and metformin for overweight\/obese women with polycystic ovary syndrome","volume":"134","author":"Ma","year":"2021","journal-title":"Chin. Med J. (Engl. )"},{"key":"10.1016\/j.prp.2025.156245_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170624","article-title":"Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats","volume":"145","author":"Wu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.prp.2025.156245_bib150","doi-asserted-by":"crossref","DOI":"10.5603\/ep.101392","article-title":"Polycystic ovary syndrome and type 1 diabetes - the current state of knowledge","author":"Cichocka","year":"2024","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.prp.2025.156245_bib151","article-title":"Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.prp.2025.156245_bib152","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fendo.2019.00189","article-title":"The effect of exenatide on cardiovascular risk markers in women with polycystic ovary syndrome","volume":"10","author":"Dawson","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib153","doi-asserted-by":"crossref","first-page":"108935","DOI":"10.1016\/j.diabres.2021.108935","article-title":"Semaglutide reduces fat accumulation in the tongue: a randomized single-blind, pilot study","volume":"178","author":"Jensterle","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.prp.2025.156245_bib154","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","article-title":"Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial","volume":"35","author":"Nylander","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.prp.2025.156245_bib155","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/obr.12720","article-title":"Pharmacologic therapy to induce weight loss in women who have obesity\/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis","volume":"19","author":"Wang","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.prp.2025.156245_bib156","article-title":"Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: a randomized, open-label, noninferiority trial","volume":"24","author":"C. M","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118533","article-title":"Phoenixin-14 stimulates proliferation and insulin secretion in insulin producing INS-1E cells","volume":"1866","author":"Billert","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.prp.2025.156245_bib158","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbalip.2018.09.006","article-title":"Phoenixin-14 stimulates differentiation of 3T3-L1 preadipocytes via cAMP\/Epac-dependent mechanism","volume":"1863","author":"Billert","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.prp.2025.156245_bib159","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.prp.2025.156245_bib160","doi-asserted-by":"crossref","first-page":"176742","DOI":"10.1016\/j.ejphar.2024.176742","article-title":"Dapagliflozin attenuates fat accumulation and insulin resistance in obese mice with polycystic ovary syndrome","volume":"977","author":"Lin","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib161","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.5114\/amsad.2021.105314","article-title":"Empagliflozin therapy and insulin resistance-associated disorders: effects and promises beyond a diabetic state","volume":"6","author":"Papaetis","year":"2021","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"10.1016\/j.prp.2025.156245_bib162","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01410-y","article-title":"Bisphenol a downregulates GLUT4 expression by activating aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome","volume":"22","author":"Shi","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.prp.2025.156245_bib163","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1021\/acs.chemrestox.8b00371","article-title":"Impact of CH223191-induced mitochondrial dysfunction on its aryl hydrocarbon receptor agonistic and antagonistic activities","volume":"32","author":"Mohammadi-Bardbori","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.prp.2025.156245_bib164","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-031-32371-3_4","article-title":"Control of arterial hypertension by the AhR blocker CH-223191: a chronopharmacological study in chronic intermittent hypoxia conditions","volume":"1427","author":"Pimp\u00e3o","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2025.156245_bib165","article-title":"Berberine for adjunct\/alternative treatment of dyslipidemia: a literature review","volume":"15","author":"Evbayekha","year":"2023"},{"key":"10.1016\/j.prp.2025.156245_bib166","article-title":"Study on the effect of berberine, myoinositol, and metformin in women with polycystic ovary syndrome: a prospective randomised study","volume":"14","author":"Mishra","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2025.156245_bib167","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib168","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.tem.2020.09.002","article-title":"Sitagliptin\/metformin: a new medical treatment in polycystic ovary syndrome","volume":"31","author":"Daneshjou","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib169","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41598-022-27301-9","article-title":"STREAM study investigators, efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study","volume":"13","author":"Nagao","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib170","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/dc06-0703","article-title":"Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes","volume":"29","author":"Aschner","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prp.2025.156245_bib171","first-page":"12","article-title":"Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases","volume":"34","author":"Zhong","year":"2016","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.prp.2025.156245_bib172","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0971-5916.166527","article-title":"The role of vitamin D in polycystic ovary syndrome","volume":"142","author":"Lin","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.prp.2025.156245_bib173","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1097\/MS9.0000000000000879","article-title":"Vitamin D and polycystic ovary syndrome (PCOS): a review","volume":"85","author":"Mohan","year":"2023","journal-title":"Ann. Med. Surg. (Lond)"},{"key":"10.1016\/j.prp.2025.156245_bib174","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome","volume":"12","author":"Ostadmohammadi","year":"2019","journal-title":"J. Ovarian. Res."},{"key":"10.1016\/j.prp.2025.156245_bib175","article-title":"Vitamin D supplementation in the treatment of polycystic ovary syndrome: A meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2025.156245_bib176","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.3390\/ijms241310976","article-title":"The role of NLRP3 inflammasome in obesity and PCOS\u2014A systematic review and Meta-Analysis","volume":"24","author":"Alenezi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib177","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing","volume":"23","author":"Sadeghi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib178","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of Obesity-Associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib179","doi-asserted-by":"crossref","first-page":"107358","DOI":"10.1016\/j.intimp.2020.107358","article-title":"NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages","volume":"92","author":"Shi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib180","doi-asserted-by":"crossref","first-page":"3050487","DOI":"10.1155\/2020\/3050487","article-title":"Pioglitazone metformin complex improves polycystic ovary syndrome comorbid psychological distress via inhibiting NLRP3 inflammasome activation: a prospective clinical study","volume":"2020","author":"Guo","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.prp.2025.156245_bib181","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12020-022-03191-9","article-title":"Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity","volume":"78","author":"Olaniyi","year":"2022","journal-title":"Endocrine"},{"issue":"Suppl 2","key":"10.1016\/j.prp.2025.156245_bib182","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1185\/030079906X121002","article-title":"A fixed-dose combination of pioglitazone and metformin: a promising alternative in metabolic control","volume":"22","author":"Seufert","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.prp.2025.156245_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1101091","article-title":"Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects","volume":"13","author":"Farrag","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib184","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/db09-1568","article-title":"MAGIC investigators, detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans","volume":"59","author":"Ingelsson","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2025.156245_bib185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/medicina56110573","article-title":"Effects of the CB1 receptor antagonists AM6545 and AM4113 on insulin resistance in a high-fructose high-salt rat model of metabolic syndrome","volume":"56","author":"Eid","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.prp.2025.156245_bib186","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/leu.2011.356","article-title":"MicroRNAs in inflammation and immune responses","volume":"26","author":"Contreras","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2025.156245_bib187","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2478\/enr-2023-0032","article-title":"The role of kisspeptin in the pathogenesis of a polycystic ovary syndrome","volume":"57","author":"Aasif","year":"2023","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.prp.2025.156245_bib188","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-020-0363-7","article-title":"Metabolic regulation of kisspeptin \u2014 the link between energy balance and reproduction","volume":"16","author":"Navarro","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib189","article-title":"Role of kisspeptin on Hypothalamic-Pituitary-Gonadal pathology and its effect on reproduction","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2025.156245_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.925206","article-title":"The role of kisspeptin in the control of the Hypothalamic-Pituitary-Gonadal axis and reproduction","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib191","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/humrep\/dex253","article-title":"A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a phase 2 randomized controlled trial","volume":"32","author":"Abbara","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib192","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of Kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib193","article-title":"Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo","volume":"12","author":"d\u2019Anglemont de Tassigny","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156245_bib194","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13201","article-title":"Invited review: translating kisspeptin and neurokinin b biology into new therapies for reproductive health","volume":"34","author":"Mills","year":"2022","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.prp.2025.156245_bib195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dmu009","article-title":"The kisspeptin-GnRH pathway in human reproductive health and disease","volume":"20","author":"Skorupskaite","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.prp.2025.156245_bib196","article-title":"Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis","volume":"94","author":"Cn","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib197","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fertnstert.2023.10.031","article-title":"Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals","volume":"121","author":"Abbara","year":"2024","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prp.2025.156245_bib198","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1172\/JCI139681","article-title":"Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders","volume":"130","author":"Abbara","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2025.156245_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179156","article-title":"In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation","volume":"12","author":"Albers-Wolthers","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156245_bib200","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/humrep\/deae153","article-title":"Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome","volume":"39","author":"Coutinho","year":"2024","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib201","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin b receptor antagonism in women with polycystic ovary syndrome: a randomized, Placebo-Controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib202","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/humrep\/deaa104","article-title":"Kisspeptin and neurokinin b interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome","volume":"35","author":"Skorupskaite","year":"2020","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib203","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Prague","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.156245_bib204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/jc.2015-3621","article-title":"The NK3 receptor antagonist ESN364 suppresses sex hormones in men and women","volume":"101","author":"Fraser","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib205","doi-asserted-by":"crossref","first-page":"e3221","DOI":"10.1210\/clinem\/dgab108","article-title":"Elinzanetant (NT-814), a neurokinin 1,3 receptor antagonist, reduces estradiol and progesterone in healthy women","volume":"106","author":"Pawsey","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib206","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1210\/clinem\/dgab602","article-title":"Inhibiting Kiss1 neurons with kappa opioid receptor agonists to treat polycystic ovary syndrome and vasomotor symptoms","volume":"107","author":"McCarthy","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib207","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104809118","article-title":"Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-\u03b2 family","volume":"118","author":"Hart","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156245_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.975880","article-title":"Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus","volume":"14","author":"Tan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib209","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms23084334","article-title":"The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome","volume":"23","author":"Bednarz","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib210","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.3390\/ijms241210164","article-title":"Novel antidiabetic agents and their effects on lipid profile: a single shot for several cardiovascular targets","volume":"24","author":"Piccirillo","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib211","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"E.-H. K","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12902-023-01500-5","article-title":"Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.prp.2025.156245_bib213","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","article-title":"Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome","volume":"14","author":"Siamashvili","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib214","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/DMSO.S451129","article-title":"Effects of Glucagon-Like Peptide-1 receptor agonists on gut microbiota in Dehydroepiandrosterone-Induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention","volume":"17","author":"Xiong","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.prp.2025.156245_bib215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prp.2025.156245_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.945609","article-title":"Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome","volume":"13","author":"Xing","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib217","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s43032-024-01503-0","article-title":"Liraglutide improves PCOS symptoms in rats by targeting FDX1","volume":"31","author":"Ji","year":"2024","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib218","article-title":"Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone","volume":"39","author":"G","year":"2023","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib219","article-title":"Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF\u2011\u03baB signaling pathway in polycystic ovary syndrome mice, drug design","volume":"18","author":"L. M","year":"2024","journal-title":"Dev. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12933-024-02147-9","article-title":"Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS clinical trial program","volume":"23","author":"Nicholls","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.prp.2025.156245_bib221","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials","volume":"38","author":"A. de A.D.H.M. B","year":"2024","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.prp.2025.156245_bib222","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jdi.13255","article-title":"Sodium\u2013glucose cotransporters: functional properties and pharmaceutical potential","volume":"11","author":"Sano","year":"2020","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.prp.2025.156245_bib223","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/ijms22052576","article-title":"Impact of SGLT-2 inhibition on cardiometabolic abnormalities in a rat model of polycystic ovary syndrome","volume":"22","author":"Pruett","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib224","article-title":"Exenatide, dapagliflozin, or Phentermine\/Topiramate differentially affect metabolic profiles in polycystic ovary syndrome","volume":"106","author":"Ke","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib225","article-title":"SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model","volume":"11","author":"Mm","year":"2023","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib226","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/dom.14495","article-title":"Licogliflozin versus placebo in women with polycystic ovary syndrome: a randomized, double-blind, phase 2 trial","volume":"23","author":"Tan","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib227","article-title":"Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib228","article-title":"Dapagliflozin attenuates fat accumulation and insulin resistance in obese mice with polycystic ovary syndrome","volume":"977","author":"L. B","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib229","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.830401","article-title":"A Meta-Analysis of the effect of sodium glucose Cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome","volume":"13","author":"Sinha","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib230","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neuroscience.2013.07.057","article-title":"Phoenixin: a novel peptide in rodent sensory ganglia","volume":"250","author":"Lyu","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.prp.2025.156245_bib231","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2020.05.101","article-title":"Levels of the neuropeptide phoenixin-14 and its receptor GRP173 in the hypothalamus, ovary and periovarian adipose tissue in rat model of polycystic ovary syndrome","volume":"528","author":"Kalamon","year":"2020","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156245_bib232","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1210\/me.2016-1039","article-title":"Phoenixin activates immortalized GnRH and kisspeptin neurons through the novel receptor GPR173","volume":"30","author":"Treen","year":"2016","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib233","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/REP-19-0025","article-title":"Effect of the neuropeptide phoenixin and its receptor GPR173 during folliculogenesis","volume":"158","author":"Nguyen","year":"2019","journal-title":"Reproduction"},{"key":"10.1016\/j.prp.2025.156245_bib234","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2826.2012.02381.x","article-title":"A novel reproductive peptide, phoenixin","volume":"25","author":"Yosten","year":"2013","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.prp.2025.156245_bib235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cca.2017.06.013","article-title":"Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome","volume":"471","author":"Ullah","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2025.156245_bib236","first-page":"3519","article-title":"Serum Phoenixin-14 levels of women with polycystic ovary syndrome increase proportionally with BMI","volume":"27","author":"Cundubey","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib237","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00424-022-02739-y","article-title":"Linking mitochondrial dynamics and fertility: promoting fertility by phoenixin through modulation of ovarian expression of GnRH receptor and mitochondrial dynamics proteins DRP-1 and Mfn-2","volume":"474","author":"Basha","year":"2022","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.prp.2025.156245_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1076800","article-title":"Current state of phoenixin\u2014the implications of the pleiotropic peptide in stress and its potential as a therapeutic target","volume":"14","author":"Friedrich","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib239","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13398","article-title":"Phoenixin knockout mice show no impairment in fertility or differences in metabolic response to a high-fat diet, but exhibit behavioral differences in an open field test","volume":"36","author":"McIlwraith","year":"2024","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib240","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.3390\/jcm12226991","article-title":"Increased serum levels of Phoenixin-14, Nesfatin-1 and dopamine are associated with positive pregnancy rate after ovarian stimulation","volume":"12","author":"Pir\u00f3g","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2025.156245_bib241","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/en.2018-00675","article-title":"Endoplasmic reticulum stress activated by androgen enhances apoptosis of granulosa cells via induction of death receptor 5 in PCOS","volume":"160","author":"Azhary","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2025.156245_bib242","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaab003","article-title":"Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome","volume":"27","author":"Kunitomi","year":"2021","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib243","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12860-022-00449-y","article-title":"High levels of follicular fluid testosterone could impair oocyte developmental competency via affecting aryl hydrocarbon receptor pathway in PCOS patients","volume":"23","author":"Eini","year":"2022","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.156245_bib244","doi-asserted-by":"crossref","first-page":"345","DOI":"10.32794\/mr112500158","article-title":"Why are aging and stress associated with dementia, cancer, and other diverse medical conditions? Role of pineal melatonin interactions with the HPA axis in mitochondrial regulation via BAG-1","volume":"6","author":"Anderson","year":"2023","journal-title":"Melatonin Res."},{"key":"10.1016\/j.prp.2025.156245_bib245","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/09513590.2020.1832066","article-title":"Association between polycystic ovary syndrome and the polymorphisms of aryl hydrocarbon receptor repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 genes","volume":"37","author":"Chung","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib246","first-page":"24","article-title":"Polycystic ovary syndrome pathophysiology: integrating systemic, CNS and circadian processes","volume":"29","author":"Anderson","year":"2024","journal-title":"FBL"},{"key":"10.1016\/j.prp.2025.156245_bib247","doi-asserted-by":"crossref","first-page":"A773","DOI":"10.1210\/jendso\/bvab048.1573","article-title":"Upregulation of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to the PCOS pathophysiology","volume":"5","author":"Kunitomi","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.prp.2025.156245_bib248","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/ijms23052424","article-title":"A connecting link between hyaluronan synthase 3-Mediated hyaluronan production and epidermal function","volume":"23","author":"Ota","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib249","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humupd\/dml062","article-title":"Molecular mechanisms of ovulation: co-ordination through the cumulus complex","volume":"13","author":"Russell","year":"2007","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.prp.2025.156245_bib250","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1038\/srep07647","article-title":"Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib251","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1009470206468","article-title":"Hyaluronic acid inhibits apoptosis in granulosa cells via CD44","volume":"17","author":"Kaneko","year":"2000","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib252","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11670-011-0059-6","article-title":"Correlation between hyaluronic Acid,Hyaluronic acid synthase and human renal clear cell carcinoma","volume":"23","author":"Cai","year":"2011","journal-title":"Chin. J. Cancer Res"},{"key":"10.1016\/j.prp.2025.156245_bib253","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/09513590.2018.1505844","article-title":"Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome","volume":"35","author":"Santos Sim\u00f5es","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155456","article-title":"Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression","volume":"128","author":"He","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prp.2025.156245_bib255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2019.02.002","article-title":"Hyaluronan biology: a complex balancing act of structure, function, location and context","volume":"78\u201379","author":"Garantziotis","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.prp.2025.156245_bib256","doi-asserted-by":"crossref","DOI":"10.1128\/mcb.00107-22","article-title":"The upregulation of HAS2-AS1 relates to the granulosa cell dysfunction by repressing TGF-\u03b2 signaling and upregulating HAS2","volume":"42","author":"Xiang","year":"2022","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.156245_bib257","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.matbio.2018.09.002","article-title":"Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGF\u03b2-induced EMT in breast cancer","volume":"80","author":"Kolliopoulos","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.prp.2025.156245_bib258","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/humrep\/16.12.2552","article-title":"Follistatin and activin a serum concentrations in obese and non-obese patients with polycystic ovary syndrome","volume":"16","author":"Eldar-Geva","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib259","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/humrep\/16.4.668","article-title":"Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.156245_bib260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massagu\u00e9","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.156245_bib261","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0163-7258(03)00035-4","article-title":"Genealogy, expression, and cellular function of transforming growth factor-beta","volume":"98","author":"Govinden","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib262","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719113485294","article-title":"The role of TGF-\u03b2 in polycystic ovary syndrome","volume":"21","author":"Raja-Khan","year":"2014","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib263","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1096\/fj.11-181099","article-title":"Linkage of regulators of TGF-\u03b2 activity in the fetal ovary to polycystic ovary syndrome","volume":"25","author":"Hatzirodos","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2025.156245_bib264","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/cen.12951","article-title":"Serum levels of TSP-1, NF-\u03baB and TGF-\u03b21 in polycystic ovarian syndrome (PCOS) patients in Northern China suggest PCOS is associated with chronic inflammation","volume":"83","author":"Liu","year":"2015","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2025.156245_bib265","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.fertnstert.2010.05.047","article-title":"A variant in the fibrillin-3 gene is associated with TGF-\u03b2 and inhibin b levels in women with polycystic ovary syndrome","volume":"94","author":"Raja-Khan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prp.2025.156245_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.732338","article-title":"Transforming growth factor beta 1 alters glucose uptake but not insulin signalling in human primary myotubes from women with and without polycystic ovary syndrome","volume":"12","author":"McIlvenna","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib267","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12884-023-06210-3","article-title":"Association between single nucleotide polymorphisms, TGF-\u03b21 promoter methylation, and polycystic ovary syndrome","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.prp.2025.156245_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.07.324","article-title":"Vitamin d supplementation decreases TGF beta-1 bioavailability correlating with clinical improvement in vitamin d deficient women with PCOS: a randomized placebo-controlled trial","volume":"104","author":"Irani","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prp.2025.156245_bib269","article-title":"Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ese.2024.100471","article-title":"Polystyrene microplastics and di-2-ethylhexyl phthalate co-exposure: implications for female reproductive health","volume":"22","author":"Xu","year":"2024","journal-title":"Environ. Sci. Ecotechnol."},{"key":"10.1016\/j.prp.2025.156245_bib271","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jog.13847","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-\u03b21 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats","volume":"45","author":"Wang","year":"2019","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.prp.2025.156245_bib272","doi-asserted-by":"crossref","unstructured":"H. Gao, L. Wang, Y. Lyu, H. Jin, Z. Lin, Y. Kang, Z. Li, X. Zhang, Y. Jiang, G. Zhang, Z. Tao, X. Zhang, B. Yang, X. Bai, X. Ma, S. Liu, J. Jiang, The P2X7R\/NLRP3 inflammasome axis suppresses enthesis regeneration through inflammatory and metabolic macrophage-stem cell cross-talk, Sci Adv 11 (n.d.) eadr4894. https:\/\/doi.org\/10.1126\/sciadv.adr4894.","DOI":"10.1126\/sciadv.adr4894"},{"key":"10.1016\/j.prp.2025.156245_bib273","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/CM9.0000000000001214","article-title":"NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?","volume":"134","author":"Zhou","year":"2020","journal-title":"Chin. Med J. (Engl. )"},{"key":"10.1016\/j.prp.2025.156245_bib274","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ijbiomac.2020.01.196","article-title":"Dendrobium nobile lindl. Polysaccharides improve follicular development in PCOS rats","volume":"149","author":"Zhang","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2025.156245_bib275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/ijmm.2023.5238","article-title":"Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)","volume":"51","author":"Zhang","year":"2023","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.prp.2025.156245_bib276","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1007\/s00210-024-03124-5","article-title":"Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK\/PI3K\/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3\/NF-\u03baB P65\/IL-1\u03b2 signaling pathways","volume":"397","author":"Moustafa","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib277","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a Fasting-Induced glucogenic protein hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156245_bib278","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2020.00064","article-title":"Asprosin: a novel player in metabolic diseases","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib279","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1002\/jcp.28694","article-title":"Asprosin attenuates insulin signaling pathway through PKC\u03b4-activated ER stress and inflammation in skeletal muscle","volume":"234","author":"Jung","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2025.156245_bib280","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","article-title":"Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation","volume":"486","author":"Lee","year":"2019","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib281","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.3390\/ijms241713123","article-title":"Mitochondrial dysfunction in PCOS: insights into reproductive organ pathophysiology","volume":"24","author":"Siemers","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib282","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","article-title":"Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.prp.2025.156245_bib283","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/01443615.2020.1758926","article-title":"Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome","volume":"41","author":"Deniz","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.prp.2025.156245_bib284","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","article-title":"Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome","volume":"35","author":"Alan","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib285","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/nu13020620","article-title":"Asprosin\u2014A Fasting-Induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature","volume":"13","author":"Mazur-Bialy","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2025.156245_bib286","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphar.2018.00156","article-title":"Peripheral CB1 receptor neutral antagonist, AM6545, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate induced obese mice","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib287","article-title":"FADS1-FADS2 gene cluster confers risk to polycystic ovary syndrome","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib288","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1194\/jlr.M900039-JLR200","article-title":"Disruption of FADS2 gene in mice impairs Male reproduction and causes dermal and intestinal ulceration","volume":"50","author":"Stroud","year":"2009","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.prp.2025.156245_bib289","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3945\/ajcn.112.043117","article-title":"Dietary oils and FADS1-FADS2 genetic variants modulate [13C]\u03b1-linolenic acid metabolism and plasma fatty acid composition","volume":"97","author":"Gillingham","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.prp.2025.156245_bib290","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.metabol.2009.10.022","article-title":"Role of fads1 and fads2 polymorphisms in polyunsaturated fatty acid metabolism","volume":"59","author":"Glaser","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.prp.2025.156245_bib291","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddl117","article-title":"Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids","volume":"15","author":"Schaeffer","year":"2006","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib292","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S0007114511003230","article-title":"Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and european Americans with diabetes or the metabolic syndrome","volume":"107","author":"Sergeant","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.prp.2025.156245_bib293","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.815968","article-title":"Effects of androgen Excess-Related metabolic disturbances on granulosa cell function and follicular development","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150005","article-title":"PPAR-\u03b1 inhibits DHEA-induced ferroptosis in granulosa cells through upregulation of FADS2","volume":"715","author":"Liu","year":"2024","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.156245_bib295","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/nu14051056","article-title":"FADS1 and FADS2 gene polymorphisms modulate the relationship of Omega-3 and Omega-6 fatty acid plasma concentrations in gestational weight gain: a NISAMI cohort study","volume":"14","author":"da","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2025.156245_bib296","article-title":"Meta-analysis of the efficacy of \u03c9-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome","volume":"102","author":"Huang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2025.156245_bib297","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/ijms19051325","article-title":"Fish oil ameliorates High-Fat diet induced Male mouse reproductive dysfunction via modifying the rhythmic expression of testosterone synthesis related genes","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib298","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.3390\/biomedicines10102503","article-title":"The complex roles of adipokines in polycystic ovary syndrome and endometriosis","volume":"10","author":"Sch\u00fcler-Toprak","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156245_bib299","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.2337\/diabetes.53.10.2552","article-title":"Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin","volume":"53","author":"Nogueiras","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2025.156245_bib300","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/232454","article-title":"Adipokines and the female reproductive tract","volume":"2014","author":"Reverchon","year":"2014","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib301","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/OGX.0b013e318217b0a4","article-title":"Adipokines: new emerging roles in fertility and reproduction","volume":"66","author":"Tersigni","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.prp.2025.156245_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.12.003","article-title":"New advances of adiponectin in regulating obesity and related metabolic syndromes","volume":"14","author":"Han","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.prp.2025.156245_bib303","doi-asserted-by":"crossref","unstructured":"L. Luo, M. Liu, Adiponectin: friend or foe in obesity and inflammation, Med Rev (2021) 2 (n.d.) 349\u2013362. https:\/\/doi.org\/10.1515\/mr-2022-0002.","DOI":"10.1515\/mr-2022-0002"},{"key":"10.1016\/j.prp.2025.156245_bib304","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/09513590.2010.487586","article-title":"Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes","volume":"26","author":"Pusalkar","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib305","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1369248","article-title":"The association between leptin, adiponectin levels and the ovarian reserve in women of reproductive age","volume":"15","author":"Nikolettos","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib306","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/07435800.2021.2011908","article-title":"Association between circulating adiponectin and heart rate recovery in women with polycystic ovarian syndrome","volume":"47","author":"Sun","year":"2022","journal-title":"Endocr. Res"},{"key":"10.1016\/j.prp.2025.156245_bib307","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080416","article-title":"Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome","volume":"8","author":"Comim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156245_bib308","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41598-023-50503-8","article-title":"Elevated circulating adiponectin levels do not prevent anxiety-like behavior in a PCOS-like mouse model","volume":"14","author":"Samad","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib309","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2025.156245_bib310","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.156245_bib311","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.0000168046.19884.6a","article-title":"PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin","volume":"46","author":"Clasen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2025.156245_bib312","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2021.10.022","article-title":"Effect of metformin on adiponectin in PCOS: a meta-analysis and a systematic review","volume":"267","author":"Duan","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.prp.2025.156245_bib313","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s10815-023-02900-1","article-title":"The effects of AdipoRon on cytochrome P450-related gene expression, acute steroidogenic regulatory protein, and structure of ovary in polycystic ovary syndrome model","volume":"40","author":"Hazrati","year":"2023","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib314","doi-asserted-by":"crossref","first-page":"15479","DOI":"10.3390\/ijms232415479","article-title":"The role of microRNAs in inflammation","volume":"23","author":"Das","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib315","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.prp.2025.156245_bib316","doi-asserted-by":"crossref","first-page":"14879","DOI":"10.1073\/pnas.0803230105","article-title":"A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence","volume":"105","author":"Forman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156245_bib317","first-page":"7215","article-title":"Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5\u2019UTR of RUNX3","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2025.156245_bib318","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079467","article-title":"MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene","volume":"8","author":"Dharap","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156245_bib319","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/09513590.2016.1155208","article-title":"Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome","volume":"32","author":"Nehir Aytan","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/ATVBAHA.112.300068","article-title":"MicroRNAs in immune response and macrophage polarization","volume":"33","author":"Liu","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prp.2025.156245_bib321","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"microRNA regulation of inflammatory responses","volume":"30","author":"O\u2019Connell","year":"2012","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.prp.2025.156245_bib322","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4183\/aeb.2022.13","article-title":"CIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME","volume":"18","author":"Soyman","year":"2022","journal-title":"Acta Endocrinol. (Buch )"},{"key":"10.1016\/j.prp.2025.156245_bib323","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52856-5","article-title":"Expression of microRNA in follicular fluid in women with and without PCOS","volume":"9","author":"Butler","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib324","doi-asserted-by":"crossref","first-page":"E1835","DOI":"10.1210\/jc.2013-2218","article-title":"Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression","volume":"98","author":"Murri","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156245_bib325","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1279469","article-title":"The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Physiol."},{"key":"10.1016\/j.prp.2025.156245_bib326","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.918805","article-title":"Therapeutic potential of exosomes\/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156245_bib327","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145766","article-title":"Exosome-mediated communication in pancreatic cancer: from molecular crosstalk to clinical translation","volume":"320","author":"Khan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2025.156245_bib328","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.trsl.2022.07.007","article-title":"Role and mechanism of miR-335-5p in the pathogenesis and treatment of polycystic ovary syndrome","volume":"252","author":"Zhang","year":"2023","journal-title":"Transl. Res"},{"key":"10.1016\/j.prp.2025.156245_bib329","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/IJWH.S427997","article-title":"Clinical value and mechanism exploration of serum miR-379 in Obesity-Polycystic ovary syndrome","volume":"16","author":"Huang","year":"2024","journal-title":"Int J. Women\u2019s. Health"},{"key":"10.1016\/j.prp.2025.156245_bib330","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/096368910X","article-title":"Mesenchymal stem cells","volume":"20","author":"Ding","year":"2011","journal-title":"Cell Transpl."},{"key":"10.1016\/j.prp.2025.156245_bib331","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated t cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.prp.2025.156245_bib332","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells - current trends and future prospective","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.prp.2025.156245_bib333","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.3390\/ijms25147948","article-title":"Transcriptome analysis of mesenchymal progenitor cells revealed molecular insights into metabolic dysfunction and inflammation in polycystic ovary syndrome","volume":"25","author":"Huang","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156245_bib334","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/1574888X18666230517123256","article-title":"Therapeutic potential of mesenchymal stem cells in PCOS","volume":"19","author":"Nejabati","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13048-024-01422-3","article-title":"The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway","volume":"17","author":"Abdi","year":"2024","journal-title":"J. Ovarian Res"},{"key":"10.1016\/j.prp.2025.156245_bib336","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13287-021-02472-w","article-title":"Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10","volume":"12","author":"Chugh","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.prp.2025.156245_bib337","doi-asserted-by":"crossref","first-page":"222","DOI":"10.62347\/TCZF4814","article-title":"M. Hirmiz, complete lasting reversal of polycystic ovary syndrome from intravenous umbilical cord derived mesenchymal stem cell infusion","volume":"13","author":"Prodromos","year":"2024","journal-title":"Am. J. Stem Cells"},{"key":"10.1016\/j.prp.2025.156245_bib338","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12902-024-01688-0","article-title":"Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome","volume":"24","author":"Sarvestani","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.prp.2025.156245_bib339","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.3390\/biomedicines12122859","article-title":"Chemerin and polycystic ovary syndrome: a comprehensive review of its role as a biomarker and therapeutic target","volume":"12","author":"Palomba","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156245_bib340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125721","article-title":"Harnessing MUC1 aptamer-targeted nanoparticles for precision Medicine in breast cancer","volume":"678","author":"Khan","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2025.156245_bib341","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1021\/acs.molpharmaceut.5c00473","article-title":"Translational insights into Stimuli-Responsive magnetic nanoparticles for breast cancer treatment","volume":"22","author":"Khan","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2025.156245_bib342","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1021\/acs.jcim.3c01726","article-title":"MRNDR: multihead Attention-Based recommendation network for drug repurposing","volume":"64","author":"Feng","year":"2024","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.prp.2025.156245_bib343","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-022-00895-5","article-title":"Recombinant anti-M\u00fcllerian hormone in the maturation medium improves the in vitro maturation of human immature (GV) oocytes after controlled ovarian hormonal stimulation","volume":"20","author":"Bedenk","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156245_bib344","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00210-022-02325-0","article-title":"Commiphora myrrh: a phytochemical and pharmacological update","volume":"396","author":"Batiha","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib345","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1065243","article-title":"Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: a review","volume":"13","author":"Luo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2025.156245_bib346","article-title":"The possible role furin and furin inhibitors in endometrial adenocarcinoma: a narrative review","volume":"7","author":"Al-kuraishy","year":"2023","journal-title":"Cancer Rep"},{"key":"10.1016\/j.prp.2025.156245_bib347","doi-asserted-by":"crossref","first-page":"885","DOI":"10.18203\/2320-1770.ijrcog20250522","article-title":"Association between polycystic ovary syndrome and endometrial cancer risk: a systematic review","volume":"14","author":"Alsulayem","year":"2025","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:44:23Z","timestamp":1760503463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":347,"alternative-id":["S0344033825004388"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156245","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156245"}}